- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02078791
Discomfort and Psychosocial Difficulties in Fibromyalgia (Fibroebre)
Perception of Discomfort and Psychosocial Difficulties in People With Diagnosis of Fibromyalgia and Predominant Neck Pain
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
It is a clinical trial. STUDY SUBJECTS. By random sampling will distribute women diagnosed with fibromyalgia in three groups. 30 people are expected to include in each of the three groups. Group 1. Infiltration, GPST Group 2, Group 3 GPST+ Infiltration The sample size is approximately 30 so that alpha risk of 0.05, and a lower risk beta 0.2, 29 subjects needed to detect a difference equal to or greater than 0.25 units. It is assumed that the proportion in the control group is 0.8. has estimated a loss rate of 20% follow-up.
Fibromyalgia patients attending the chronic pain unit referred by family doctors and other specialists. These are patients who have painful symptoms that could not be controlled in the first level of health care or health centers.Not form part of the study all patients with fibromyalgia but only those who have discomfort in the cervical area preferably.To include in the study the patient acceptance of its participation is required by informed consent.Anesthesiologists assigned patients into three different groups according to the intervention takes place; infiltration, TRP (Problem Solving Therapy) or both interventions. When patients have met 8-10 start TRP group. Each group will be directed by a trained professional nursing. If we if we haven't enough sample will search in Fibromyalgia Associations.
The information of all variables are entered into a database (Excel) of which will be imported to a statistical program (SPSS) for analysis.
Qualitative variables were expressed as frequencies and percentages and quantitative mediated by central tendency and (mean and standard deviation) dispersion.The relationship between variables was analyzed by the χ2, comparison of means (t-student), analysis of variance (ANOVA) and Spearman, depending on the type of variable.Multivariate analysis will be performed to try to determine factors that may promote improved quality of life / patients.
It is considered that the difference between variables is significant when the significance level is less than or equal to 0.05 (p ≤ 0.05).
Study Type
Enrollment (Actual)
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
Tarragona
-
Tortosa, Tarragona, Spain, 43500
- Hospital Verge de la Cinta
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Diagnosing Fibromyalgia.
- Diagnosing Fibromyalgia + other causative pathology of chronic pain (chronic and / or chronic low back pain neck pain).
- Acceptance of study participation by informed consent
Exclusion Criteria:
- Severe disability that makes a first indication infiltration (disc herniation and / or lumbar spinal stenosis).
- cognitive Impairment
- Life expectancy less than 12 months
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Botox infiltration
Botox infiltration in cervical region
|
botox cervical infiltration in a group
Other Names:
|
Experimental: Psychology therapy
Problem solving group therapy
|
Psychology problem solving therapy lead by specialized nurses.
Other Names:
|
Experimental: Botox infiltration & psychology therapy
Botox infiltration in cervical region and problem solving group therapy.
|
Botox infiltration in cervical region and psychology problem solving therapy lead by specialized nurses.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change in pain perception Visual Analogical Scale (VAS)
Time Frame: Baseline and 2 months
|
Baseline and 2 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change in suicidal thoughts Plutchick Scale
Time Frame: Baseline and 2 months
|
Baseline and 2 months
|
change in quality of sleep SCOPA questionnaire
Time Frame: Baseline and 2 months
|
Baseline and 2 months
|
Change in health questionnaire EQ5D5L
Time Frame: Baseline and 2 months
|
Baseline and 2 months
|
Other Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change in satisfaction and perceived usefulness questionnaire
Time Frame: Baseline and 2 months
|
Baseline and 2 months
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: PILAR MONTESÓ, phD, Rovira i Virgili University
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Nervous System Diseases
- Musculoskeletal Diseases
- Rheumatic Diseases
- Muscular Diseases
- Neuromuscular Diseases
- Fibromyalgia
- Myofascial Pain Syndromes
- Physiological Effects of Drugs
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Peripheral Nervous System Agents
- Cholinergic Agents
- Membrane Transport Modulators
- Acetylcholine Release Inhibitors
- Neuromuscular Agents
- Botulinum Toxins, Type A
- abobotulinumtoxinA
Other Study ID Numbers
- 2012LINE-01
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fibromyalgia
-
University of AberdeenCompletedFibromyalgia | Fibromyalgia, Primary | Fibromyalgia, SecondaryUnited Kingdom
-
Eli Lilly and CompanyCompletedFibromyalgia, Primary | Fibromyalgia, SecondaryMexico
-
Rasmia ElgoharyNot yet recruiting
-
Spaulding Rehabilitation HospitalNot yet recruiting
-
Cairo UniversityNot yet recruiting
-
Children's Hospital Medical Center, CincinnatiNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)Completed
-
University of UtahTerminated
-
State University of New York - Upstate Medical...CompletedFibromyalgia, PrimaryUnited States
-
University of Sao Paulo General HospitalFundação de Amparo à Pesquisa do Estado de São PauloCompleted
-
Tel-Aviv Sourasky Medical CenterCompletedFibromyalgia (FM)Israel
Clinical Trials on Botox infiltration
-
Sun Yat-sen UniversityUnknownType 2 Diabetes | Flash Glucose Monitoring | ConscienceChina
-
Centre Hospitalier Departemental VendeeCompleted
-
Centre Hospitalier Universitaire de NiceNot yet recruitingChronic Low-back PainFrance
-
Cairo UniversityUnknownMolar Incisor Hypomineralization
-
DMG Dental Material Gesellschaft mbHWithdrawnFluorosis | Oral Deseases
-
University Hospital, Clermont-FerrandCompletedHigh Grade Brain TumorFrance
-
DMG Dental Material Gesellschaft mbHCompletedFluorosis | Dental Care | Caries InfiltrationIndia
-
Rajavithi HospitalCompletedPain, Post Operative | Arthroplasty ComplicationsThailand
-
Tanta UniversityCompletedRole of Platelet Rich Plasma in Wound HealingEgypt